Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.
about
Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.Rebamipide suppresses TLR-TBK1 signaling pathway resulting in regulating IRF3/7 and IFN-α/β reduction.The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study.The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine.Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects.Mitochondrial disorders in NSAIDs-induced small bowel injury.European physicians don't like cytoprotective agents?Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.Evaluation of gastrointestinal injury and blood flow of small bowel during low-dose aspirin administration.Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide.Rebamipide: a gastrointestinal protective drug with pleiotropic activities.Correlation between Helicobacter pylori infection and low-dose aspirin use on damage of the upper gastrointestinal tract.
P2860
Q34606022-26F67446-B529-446E-9CFF-81D2655CC790Q34609698-4620281F-FAB1-4978-8226-B4288E88ABEDQ35209641-674BCD97-9007-4AF4-8FE2-0FB7750385ADQ37849580-E0044D28-7319-42C1-B75C-F07BEF52B309Q41927171-6D1DF749-35BB-4196-B00F-655366620CD0Q42015382-1071DBA1-E500-4801-9A39-FD3B051A9120Q42127560-2ACB8264-724C-4057-8C50-0F44165F56D8Q42219817-FF1D4815-0713-4DD7-B86B-43C1C2C4758DQ42721853-DB5BC1D8-3DD5-4D6F-A41D-9AA351DBF584Q42735040-67B8D7E6-5537-45E8-BEE2-5927914007AFQ43042896-1B78A540-56B0-4D69-B660-5608435D0BA8Q51346297-3AEBD1FE-7462-4A7B-B2F5-4CA5740CD607
P2860
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@en
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@nl
type
label
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@en
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@nl
prefLabel
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@en
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@nl
P2093
P2860
P356
P1476
Preliminary trial of rebamipid ...... -controlled, cross-over study.
@en
P2093
Hiroshi Takeda
Jyojyo Hirota
Kikuko Takagi
Manabu Nakagawa
Masahiro Asaka
Mototsugu Kato
Shouko Ono
Souichi Nakagawa
P2860
P304
P356
10.3164/JCBN.09-24
P577
2009-08-28T00:00:00Z